What is the benefit of inconsistent opioid agonist treatment in patients with prescription opioid use disorder?
Introduction Studies consistently show that patients with prescription opioid use disorder (OUD) respond to buprenorphine treatment. Few studies have followed these patients in the long-term. Our longitudinal research has shown opioid abstinence to be associated most strongly with opioid agonist/pa...
Main Authors: | R. Weiss, M. L. Griffin |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2023-03-01
|
Series: | European Psychiatry |
Online Access: | https://www.cambridge.org/core/product/identifier/S0924933823011963/type/journal_article |
Similar Items
-
Opioid consumption frequency and its associations with potential life problems during opioid agonist treatment in individuals with prescription-type opioid use disorder: exploratory results from the OPTIMA Study
by: Anne Bouthillier, et al.
Published: (2025-02-01) -
Nonmedical Use of Prescription Opioids: What Is the Real Problem?
by: Mary Lynch
Published: (2013-01-01) -
Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder
by: Ashish P. Thakrar, et al.
Published: (2023-02-01) -
Prescription stimulant use during long-term opioid therapy and risk for opioid use disorder
by: Jeffrey F. Scherrer, et al.
Published: (2022-12-01) -
Targeting the Orexin System for Prescription Opioid Use Disorder
by: Alessandra Matzeu, et al.
Published: (2020-04-01)